STOCK TITAN

Director at Guardant Health (GH) acquires 155 shares via RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardant Health director Steve E. Krognes acquired 155 shares of Common Stock through the vesting and exercise of Restricted Stock Units. The transaction occurred on March 31, 2026 at an exercise price of $0.00 per share, reflecting a routine equity-compensation event rather than an open-market purchase.

The 155 Restricted Stock Units converted into 155 shares of Common Stock, increasing his direct Common Stock holdings to 19,208 shares following the transaction. He also continues to hold 463 Restricted Stock Units after this vesting. The underlying award was originally granted on August 9, 2022 and vests over four years, with 25% vesting on June 30, 2023 and the remaining 75% vesting in substantially equal monthly installments over the subsequent three years.

Positive

  • None.

Negative

  • None.
Insider Krognes Steve E.
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 155 $0.00 --
Exercise Common Stock 155 $0.00 --
Holdings After Transaction: Restricted Stock Units — 463 shares (Direct); Common Stock — 19,208 shares (Direct)
Footnotes (1)
  1. This represents a restricted stock unit award granted on August 9, 2022 that vests over 4 years. 25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vests in substantially equal monthly installments during the three-year period thereafter. Not applicable for Restricted Stock Units.
RSUs exercised 155 units Restricted Stock Units converted to Common Stock on March 31, 2026
Shares acquired 155 shares Common Stock received from RSU exercise at $0.00 per share
Common shares held after 19,208 shares Direct Common Stock holdings following the transaction
RSUs remaining 463 units Restricted Stock Units held after the March 31, 2026 vesting
Exercise price $0.00 per share Price for converting RSUs into Common Stock
Grant date August 9, 2022 Original date of the Restricted Stock Unit award
Restricted Stock Units financial
"This represents a restricted stock unit award granted on August 9, 2022 that vests over 4 years."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vests over 4 years financial
"This represents a restricted stock unit award granted on August 9, 2022 that vests over 4 years."
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
Common Stock financial
"underlying_security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Krognes Steve E.

(Last)(First)(Middle)
3100 HANOVER STREET

(Street)
PALO ALTO CALIFORNIA 94304

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026M155A$019,208D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$003/31/2026M155 (1) (2)Common Stock155$0463D
Explanation of Responses:
1. This represents a restricted stock unit award granted on August 9, 2022 that vests over 4 years. 25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vests in substantially equal monthly installments during the three-year period thereafter.
2. Not applicable for Restricted Stock Units.
Remarks:
/s/ John Saia, as attorney-in-fact for Steve Krognes04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Guardant Health (GH) report for Steve E. Krognes?

Guardant Health reported that director Steve E. Krognes acquired 155 shares of Common Stock. The shares came from the vesting and exercise of 155 Restricted Stock Units on March 31, 2026, as part of his existing equity compensation award.

How many Guardant Health (GH) shares does Steve E. Krognes hold after this Form 4?

After the reported transaction, Steve E. Krognes directly holds 19,208 shares of Guardant Health Common Stock. He also continues to hold 463 Restricted Stock Units, which represent additional potential future share deliveries as they vest over time.

Was the Guardant Health (GH) insider transaction an open-market buy or a compensation event?

The transaction was a compensation-related event, not an open-market purchase. Krognes exercised and converted 155 Restricted Stock Units at an exercise price of $0.00 per share, receiving 155 shares of Common Stock as part of his previously granted equity award.

When was the Restricted Stock Unit award for Guardant Health (GH) granted and how does it vest?

The Restricted Stock Unit award was granted on August 9, 2022. Twenty-five percent of the shares vested on June 30, 2023, and the remaining seventy-five percent vest in substantially equal monthly installments over the following three-year period, subject to continued service.

How many Restricted Stock Units did Steve E. Krognes retain after this Guardant Health (GH) vesting?

Following the March 31, 2026 vesting and conversion of 155 Restricted Stock Units into Common Stock, Steve E. Krognes continues to hold 463 Restricted Stock Units. These units reflect additional equity compensation that is scheduled to vest over time under the award terms.